Subsequently, we further confirmed that ASF1B and CDK9 are the factors of a nuclear complex to promote cervical cancer progression by co-IP and colocalization of ASF1B and CDK9 in the nucleus (Fig. 6e, i). The gene discussed is ASF1B; the disease is cervical carcinoma.